Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Vivos Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 37 | 29 | −8 |
| Shares | 2.26M | 2.23M | −29.6K (−1.3%) |
| Value | $9.14M | $5.02M | −$4.12M (−45.1%) |
New holders (3)
Institutions that held Vivos Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 122,297 | $275.0K | 0.04% |
| Stephens Consulting, LLC | 3,000 | $6.75K | 0.01% |
| Bank of America Corp | 26 | $0 | 0.00% |
Sold out (11)
Institutions that held Vivos Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Virtu Financial LLC | 35,334 | $143.0K |
| Aperture Investors, LLC | 35,276 | $143.0K |
| Schonfeld Strategic Advisors LLC | 34,443 | $139.0K |
| Blueshift Asset Management, LLC | 18,826 | $76.0K |
| Jane Street Group, LLC | 14,999 | $60.0K |
| WMS Partners, LLC | 12,167 | $49.0K |
| Financial Management Professionals, Inc. | 5,897 | $24.0K |
| Cutler Group LP | 501 | $2.00K |
| Global Retirement Partners, LLC | 570 | $2.00K |
| Quantbot Technologies LP | 480 | $1.00K |
| Wagner Wealth Management, LLC | 275 | $1.00K |